123 related articles for article (PubMed ID: 18929634)
1. Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties.
Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2009 Feb; 367(1-2):86-96. PubMed ID: 18929634
[TBL] [Abstract][Full Text] [Related]
2. Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation.
Tajber L; Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2009 Feb; 367(1-2):79-85. PubMed ID: 18929631
[TBL] [Abstract][Full Text] [Related]
3. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
[TBL] [Abstract][Full Text] [Related]
4. Can low-dose combination products for inhalation be formulated in single crystalline particles?
Kumon M; Kwok PC; Adi H; Heng D; Chan HK
Eur J Pharm Sci; 2010 Apr; 40(1):16-24. PubMed ID: 20172026
[TBL] [Abstract][Full Text] [Related]
5. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation.
Amaro MI; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Dec; 421(1):99-109. PubMed ID: 21963473
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
7. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
Rattanupatam T; Srichana T
Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
[TBL] [Abstract][Full Text] [Related]
8. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.
Gilani K; Najafabadi AR; Barghi M; Rafiee-Tehrani M
J Pharm Sci; 2005 May; 94(5):1048-59. PubMed ID: 15793812
[TBL] [Abstract][Full Text] [Related]
9. New insights into respirable protein powder preparation using a nano spray dryer.
Bürki K; Jeon I; Arpagaus C; Betz G
Int J Pharm; 2011 Apr; 408(1-2):248-56. PubMed ID: 21335078
[TBL] [Abstract][Full Text] [Related]
10. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
Gad S; Tajber L; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
[TBL] [Abstract][Full Text] [Related]
12. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
[TBL] [Abstract][Full Text] [Related]
13. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
[TBL] [Abstract][Full Text] [Related]
14. Particle size dependence of polymorphism in spray-dried mannitol.
Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
[TBL] [Abstract][Full Text] [Related]
15. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
Pilcer G; Vanderbist F; Amighi K
J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
[TBL] [Abstract][Full Text] [Related]
16. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
18. Development and characterisation of metformin loaded spray dried Bora rice microspheres.
Sharma HK; Mohapatra J; Nath LK
Pak J Pharm Sci; 2013 Jan; 26(1):17-22. PubMed ID: 23261723
[TBL] [Abstract][Full Text] [Related]
19. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
[TBL] [Abstract][Full Text] [Related]
20. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction.
Belotti S; Rossi A; Colombo P; Bettini R; Rekkas D; Politis S; Colombo G; Balducci AG; Buttini F
Int J Pharm; 2014 Aug; 471(1-2):507-15. PubMed ID: 24886692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
